Putnam Investments LLC Cytokinetics Inc Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Putnam Investments LLC holds 365,335 shares of CYTK stock, worth $21.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
365,335
Previous 217,849
67.7%
Holding current value
$21.2 Million
Previous $6.42 Million
375.32%
% of portfolio
0.04%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
126MCall Options Held
3.27MPut Options Held
2.01M-
Black Rock Inc. New York, NY14.7MShares$851 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$663 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.14MShares$472 Million0.28% of portfolio
-
Wellington Management Group LLP Boston, MA7.51MShares$435 Million0.07% of portfolio
-
State Street Corp Boston, MA6.55MShares$380 Million0.02% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.46B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...